Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial
NCT02704520
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
441
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
DIAGNOSTIC_TEST:
High resolution MRI scan
DIAGNOSTIC_TEST:
mrTRG assessment
Sponsor
Imperial College London